First Berlin Reaffirms Buy Recommendation for MPH Health Care AG

First Berlin Equity Research GmbH released an updated research report on MPH Health Care AG, maintaining its "BUY" recommendation while adjusting the target price from €113 to €108. This revision followed MPH's report of a substantial increase in its net asset value (NAV) for the six-month period ending in June 2024.

The NAV rose by 30%, reaching €326 million, marking a 58% year-over-year growth. This upward trend was mirrored in the NAV per share, which climbed to €76. Significant growth was also noted in M1 Kliniken shares, rising by 63% due primarily to a positive mid-term outlook, attracting interest from private equity firms.

Meanwhile, CR Energy, another core asset of MPH, reported solid results for 2023, although its shares dipped by 8% during the same period. The focus remains on M1 Kliniken's expansion plans and CR Energy’s flourishing business sectors.